Royalty Pharma plc (RPRX)

Sector:Health Care
Super Investor Stats:
Ownership count:3
Ownership rank:299
% of all portfolios:0.254%
Hold Price * :$47.97
History Portfolio Manager Activity Share change % change to portfolio ▼
Q1  2026
≡ Torray Funds Reduce 13.29% 98,930 0.74
≡ Samantha McLemore - Patient Capital Management Add 9.30% 310,041 0.55
≡ Pat Dorsey - Dorsey Asset Management Add 0.76% 17,101 0.07
Q4  2025
≡ Samantha McLemore - Patient Capital Management Add 6.92% 215,825 0.32
≡ Pat Dorsey - Dorsey Asset Management Reduce 3.87% 90,980 0.31
≡ Torray Funds Add 5.90% 41,472 0.25
Q3  2025
≡ Pat Dorsey - Dorsey Asset Management Buy 2,350,449 7.45
≡ Viking Global Investors Sell 100.00% 2,597,460 0.27
≡ Samantha McLemore - Patient Capital Management Add 4.35% 129,862 0.18
≡ Torray Funds Add 2.05% 14,107 0.07
Q2  2025
≡ Torray Funds Reduce 20.10% 173,242 0.91
≡ Viking Global Investors Reduce 75.41% 7,966,479 0.83
≡ Samantha McLemore - Patient Capital Management Add 0.52% 15,342 0.02
Q1  2025
≡ Torray Funds Add 26.02% 178,011 0.83
≡ Samantha McLemore - Patient Capital Management Add 3.39% 97,557 0.16
≡ Viking Global Investors Reduce 13.47% 1,643,946 0.16
Q4  2024
≡ Samantha McLemore - Patient Capital Management Add 40.85% 833,894 0.98
≡ Torray Funds Reduce 20.27% 173,912 0.64
≡ Viking Global Investors Add 0.94% 113,864 0.01
Q3  2024
≡ Samantha McLemore - Patient Capital Management Add 43.30% 616,805 0.86
≡ Torray Funds Add 23.70% 164,361 0.65
≡ Viking Global Investors Add 1.04% 123,963 0.01
Q2  2024
≡ Torray Funds Add 3.51% 23,498 0.09
≡ Viking Global Investors Add 4.22% 484,511 0.05
≡ Samantha McLemore - Patient Capital Management Add 0.32% 4,572 0.01
Q1  2024
≡ Torray Funds Add 32.49% 164,320 0.75
≡ Samantha McLemore - Patient Capital Management Add 13.15% 165,038 0.24
≡ Viking Global Investors Add 13.86% 1,398,130 0.16
Q4  2023
≡ Samantha McLemore - Patient Capital Management Buy 1,254,780 1.87
≡ Torray Funds Add 22.56% 93,107 0.42
≡ Viking Global Investors Add 6.58% 623,216 0.06
Q3  2023
≡ Viking Global Investors Reduce 3.93% 386,731 0.04
≡ Torray Funds Reduce 0.29% 1,182 0.01
Q2  2023
≡ Torray Funds Add 201.68% 276,643 1.47
≡ Viking Global Investors Reduce 12.08% 1,353,317 0.17
Q1  2023
≡ Viking Global Investors Add 11.95% 1,195,738 0.20
≡ Torray Funds Reduce 0.14% 199 0.00
Q4  2022
≡ Viking Global Investors Reduce 8.02% 873,083 0.17
≡ Torray Funds Reduce 1.19% 1,653 0.01
Q3  2022
≡ Viking Global Investors Reduce 12.04% 1,489,100 0.28
≡ Torray Funds Add 0.01% 12 0.00
Q2  2022
≡ Viking Global Investors Add 14.92% 1,606,222 0.31
≡ Torray Funds Add 5.26% 6,942 0.06
≡ Warren Buffett - Berkshire Hathaway Sell 100.00% 1,496,372 0.02
Q1  2022
≡ Warren Buffett - Berkshire Hathaway Reduce 82.70% 7,151,896 0.10
≡ Viking Global Investors Add 4.35% 449,094 0.07
≡ Torray Funds Reduce 4.26% 5,871 0.04
Q4  2021
≡ Torray Funds Buy 137,941 0.81
≡ Viking Global Investors Add 149.13% 6,174,870 0.71
≡ Warren Buffett - Berkshire Hathaway Reduce 34.21% 4,497,634 0.05
Q3  2021
≡ Warren Buffett - Berkshire Hathaway Buy 13,145,902 0.16
≡ Viking Global Investors Add 27.85% 901,854 0.09
Q2  2021
≡ Viking Global Investors Add 57.08% 1,176,901 0.15
≡ Lee Ainslie - Maverick Capital Sell 100.00% 7,342 0.00
Q1  2021
≡ Viking Global Investors Reduce 9.85% 225,247 0.03
≡ Lee Ainslie - Maverick Capital Buy 7,342 0.00
Q4  2020
≡ Viking Global Investors Add 17.40% 338,936 0.05
Q3  2020
≡ Viking Global Investors Reduce 22.54% 566,921 0.09
Q2  2020
≡ Viking Global Investors Buy 2,514,985 0.53

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.